Goldman Sachs’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.39M | Buy |
|
|||||
|
2025
Q1 | $7.25M | Buy |
|
|||||
|
2024
Q4 | $1.74M | Sell |
|
|||||
|
2024
Q3 | $2.16M | Buy |
|
|||||
|
2024
Q2 | $486K | Sell |
|
|||||
|
2024
Q1 | $451K | Buy |
|
|||||
|
2023
Q4 | $316K | Sell |
|
|||||
|
2023
Q3 | $415K | Sell |
|
|||||
|
2023
Q2 | $511K | Sell |
|
|||||
|
2023
Q1 | $820K | Sell |
|
|||||
|
2022
Q4 | $895K | Sell |
|
|||||
|
2022
Q3 | $1.24M | Sell |
|
|||||
|
2022
Q2 | $1.98M | Sell |
|
|||||
|
2022
Q1 | $4.59M | Buy |
|
|||||
|
2021
Q4 | $2.7M | Buy |
|
|||||
|
2021
Q3 | $1.23M | Buy |
|
|||||
|
2021
Q2 | $317K | Buy |
|
|||||
|
2021
Q1 | $149K | Sell |
|
|||||
|
2020
Q4 | $210K | Sell |
|
|||||
|
2020
Q3 | $795K | Sell |
|
|||||
|
2020
Q2 | $3.03M | Sell |
|
|||||
|
2020
Q1 | $1.96M | Buy |
|
|||||
|
2019
Q4 | $239K | Sell |
|
|||||
|
2019
Q3 | $159K | Sell |
|
|||||
|
2019
Q2 | $418K | Sell |
|
|||||
|
2019
Q1 | $790K | Buy |
|
|||||
|
2018
Q4 | $334K | Sell |
|
|||||
|
2018
Q3 | $856K | Sell |
|
|||||
|
2018
Q2 | $2.58M | Buy |
|
|||||
|
2018
Q1 | $533K | Buy |
|
|||||
|
2017
Q4 | $275K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $330K | Sell |
|
|||||
|
2017
Q1 | $785K | Sell |
|
|||||
|
2016
Q4 | $892K | Sell |
|
|||||
|
2016
Q3 | $2.1M | Sell |
|
|||||
|
2016
Q2 | $2.37M | Sell |
|
|||||
|
2016
Q1 | $3.09M | Buy |
|
|||||
|
2015
Q4 | $3M | Sell |
|
|||||
|
2015
Q3 | $4.29M | Sell |
|
|||||
|
2015
Q2 | $9.18M | Buy |
|
|||||
|
2015
Q1 | $8.57M | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $201K | Buy |
|
|||||
|
2014
Q2 | $53K | Sell |
|
|||||
|
2014
Q1 | $219K | Sell |
|
|||||
|
2013
Q4 | $116K | Buy |
|